Adjuvant interferon alfa-2b for high-risk melanoma.

  • S Retsas
  • Journal of Clinical Oncology, June 1996, American Society of Clinical Oncology (ASCO)
  • DOI: 10.1200/jco.1996.14.6.1968

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Spyros Retsas